$88.25
-0.36[-0.41%]
At close: Apr 25
$88.25
0[0.00%]
After Hours: 5:06PM EDT
Edwards Lifesciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Edwards Lifesciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
07/24/2024 | PM | EW | Q2 | $0.66 | — | — | — | $1.53B | — | — | — | Get Alert |
04/25/2024 | PM | EW | Q1 | $0.62 | $0.64 | $0.66 | 3.12% | $1.46B | $1.57B | $1.60B | 1.78% | Get Alert |
02/06/2024 | PM | EW | Q4 | $0.64 | $0.64 | $0.64 | 0.00% | $1.35B | $1.49B | $1.53B | 2.95% | Get Alert |
10/25/2023 | PM | EW | Q3 | $0.61 | $0.59 | $0.59 | 0.00% | $1.32B | $1.48B | $1.48B | 0.07% | Get Alert |
07/26/2023 | PM | EW | Q2 | $0.63 | $0.65 | $0.66 | 1.54% | $1.37B | $1.50B | $1.53B | 2.00% | Get Alert |
04/26/2023 | PM | EW | Q1 | $0.60 | $0.61 | $0.62 | 1.64% | $1.34B | $1.39B | $1.46B | 5.04% | Get Alert |
01/31/2023 | PM | EW | Q4 | $0.51 | $0.61 | $0.64 | 4.92% | $1.33B | $1.33B | $1.35B | 1.35% | Get Alert |
10/27/2022 | PM | EW | Q3 | $0.54 | $0.62 | $0.61 | -1.61% | $1.31B | $1.33B | $1.32B | -0.83% | Get Alert |
07/28/2022 | PM | EW | Q2 | $0.64 | $0.64 | $0.63 | -1.56% | $1.38B | $1.40B | $1.37B | -1.86% | Get Alert |
04/26/2022 | PM | EW | Q1 | $0.54 | $0.57 | $0.60 | 5.26% | $1.22B | $1.31B | $1.34B | 2.37% | Get Alert |
01/26/2022 | PM | EW | Q4 | $0.50 | $0.55 | $0.51 | -7.27% | $1.19B | $1.36B | $1.33B | -2.21% | Get Alert |
10/27/2021 | PM | EW | Q3 | $0.51 | $0.53 | $0.54 | 1.89% | $1.14B | $1.32B | $1.31B | -0.76% | Get Alert |
07/29/2021 | PM | EW | Q2 | $0.34 | $0.55 | $0.64 | 16.36% | $925.00M | $1.28B | $1.38B | 7.50% | Get Alert |
04/20/2021 | PM | EW | Q1 | $0.50 | $0.47 | $0.54 | 14.89% | $1.13B | $1.16B | $1.22B | 4.91% | Get Alert |
01/27/2021 | PM | EW | Q4 | $0.49 | $0.53 | $0.50 | -5.66% | $1.17B | $1.19B | $1.19B | 0.17% | Get Alert |
10/21/2020 | PM | EW | Q3 | $0.49 | $0.44 | $0.51 | 15.91% | $1.09B | $1.08B | $1.14B | 5.65% | Get Alert |
07/23/2020 | PM | EW | Q2 | $0.47 | $0.17 | $0.34 | 100.00% | $1.09B | $789.42M | $925.00M | 17.17% | Get Alert |
04/23/2020 | PM | EW | Q1 | $0.44 | $0.44 | $0.50 | 13.64% | $993.00M | $1.08B | $1.13B | 4.54% | Get Alert |
01/30/2020 | PM | EW | Q4 | $0.39 | $0.49 | $0.49 | 0.00% | $977.70M | $1.14B | $1.17B | 2.98% | Get Alert |
Edwards Lifesciences (EW) is scheduled to report earnings on July 24, 2024. The last reported earnings were for reported on April 25, 2024 for Q1.
The Actual EPS was $0.66, which beat the estimate of $0.64.
The Actual Revenue was $1.6B, which beat the estimate of $1.6B.
Browse earnings estimates, EPS, and revenue on all stocks.